CD8A and neoplasm: Factors that may increase BCC’s immunogenicity include its high rate of cancer-testis antigen expression [17], copious numbers of tumor-infiltrating CD8+ T cells [18], and a genetic mutational burden which is among the highest reported in any human cancer type [14, 19–21].